{"id":"https://openalex.org/A5117723322","orcid":"https://orcid.org/0009-0008-0256-4922","observed_orcids":["https://orcid.org/0009-0008-0256-4922"],"display_name":"Farah Alshamasneh","raw_author_names":["Farah Alshamasneh"],"full_name":"Farah Alshamasneh","works_count":3,"cited_by_count":1,"summary_stats":{"2yr_mean_citedness":0.3333333333333333,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5117723322","orcid":"https://orcid.org/0009-0008-0256-4922","observed_orcids":["https://orcid.org/0009-0008-0256-4922"]},"affiliations":[{"institution":{"id":"https://openalex.org/I157392197","ror":"https://ror.org/04a1r5z94","display_name":"Hashemite University","country_code":"JO","type":"education","lineage":["https://openalex.org/I157392197"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I157392197","ror":"https://ror.org/04a1r5z94","display_name":"Hashemite University","country_code":"JO","type":"education","lineage":["https://openalex.org/I157392197"]}],"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","count":1,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","count":1,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","count":1,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11660","display_name":"Blood groups and transfusion","count":1,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","value":3.18e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","value":1.69e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11961","display_name":"Neonatal and Maternal Infections","value":7.7e-06,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","value":6e-06,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12297","display_name":"Otolaryngology and Infectious Diseases","value":5.7e-06,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.8544999957084656},{"id":"143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","score":0.650285542011261},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.523425817489624},{"id":"2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","score":0.42980000376701355},{"id":"177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","score":0.3630000054836273}],"counts_by_year":[{"year":2025,"works_count":2,"oa_works_count":1,"cited_by_count":0},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":1}],"display_name_alternatives":["Farah Alshamasneh"],"block_key":"f alshamasneh","works_api_url":"https://api.openalex.org/works?filter=author.id:A5117723322","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5117723322","updated_date":"2026-11-08T12:57:04","created_date":"2025-10-10T00:00:00"}